February was filled with fabulous podcast guests that delivered quality interviews for our life science listeners.
We appreciate that your time is precious and there’s a lot to keep on top of in the outsourcing space, so we’ve condensed February’s interviews into a bitesize summary, meaning you never need to miss a moment and you can bookmark your favourite episodes to listen to at your leisure.
February’s podcast playlist:
The Opportunistic Entrepreneur
This interview covers market needs, innovative medicines development and business growth.
Episode 67 introduced the remarkable Ross Burn, Chief Executive at CatSci Ltd.
During the episode, you’ll hear Ross talk about pivoting in-line with the needs of the market. He also shares how his aim of becoming an innovative medicines development partner led to remarkable business growth and how the pandemic helped put life sciences and pharma R&D on the map.
Tune in learn about:
- The journey to creating a successful business from an opportunistic AZ spin-out
- Finding the courage to pivot in-line with the needs of the market
- How big aims can lead to becoming an innovative medicines development partner with a $1 billion valuation
- Overcoming the challenge of raising capital as an oversubscribed CRO with a 50% compound growth rate
>> Listen on Apple
>> Listen on Spotify
The Latin American Logistics Leader
Pod 68 covers industry revelations, trends, timeless lessons and the complexities of doing business in Latin America.
In episode 68 listen to Raman interview the incredible Jaqueline Escotero – hear her reveal key industry trends as we enter the post-pandemic world.
Jaqueline Escotero is the Regional Vice President for Latin America at World Courier. She is an experienced executive, with 29 years of international experience in the healthcare industry, and the global Chairperson of WIN – “Women’s Impact Network”.
You’ll come away from the episode knowing all about:
- The misconceptions, characteristics and challenges of doing business in Latin America’s pharmaceutical sector
- The immense complexity and level of responsibility involved in vaccine storage and distribution over the last year
- The timeless lessons gleaned from a lifetime spent doing international business all over the world
- A key trend that everyone in our sector needs to be prepared for
>> Listen on Apple
>> Listen on Spotify
In this digitally-focussed episode, we cover the pandemic’s impact on pharma, adapting technology to gain competitive advantage and embracing transformative approaches.
Episode 69 features David Leitham, Senior Vice President and General Manager of Aspen Technology. David has driven digital transformation efforts for multiple businesses, while integrating and harmonising product divisions for improved organisation and performance.
Tune in to discover why a transformative approach is needed to deal with new therapeutics and modalities during a discussion that covers:
- How the pandemic created an inflexion point for companies in pharma
- Why adapting technology leveraged competitive advantage
- Driving change in the contract services space
- Being open to failure, embracing the wrong calls and treating every set back as a learning opportunity
>> Listen on Apple
>> Listen on Spotify
From Corporate Rebel to CDMO Entrepreneur
Learn about the role a CDMO can play in encouraging sustainability within the sector.
Episode 70 introduces Hanns-Christian Mahler, CEO at ten23 health, whose incredible expertise in formulation development, process development & validation, packaging/device development and integration, sterile manufacturing and regulatory submissions makes this a podcast not to be missed.
You’ll learn about the driving forces behind the growth of small-scale sterile biologics during a discussion that covers:
- Transitioning from the structure and scale of Merck, Roche and Lonza into an entrepreneurial start-up CDMO leader.
- Having a business purpose focused on the ‘triple-bottom line’ – patients, people and planet.
- Tips and insights on how a CDMO can play its part in encouraging sustainability
- Reducing environmental impact and managing footprints, across all levels
- Insights into the opportunity and growth in small-scale sterile biologics, and some of the drivers behind these trends
>> Listen on Apple
>> Listen on Spotify
We hope you enjoy February’s interviews (alongside our back catalogue). You can listen to all of our episodes right here on the Molecule to Market, on Spotify or on Apple Podcasts.
Please leave a review (we like five star ratings the best!) and share the podcasts with your colleagues.
If you’d like to share your feedback, nominate a future guest, or tell us what you’d love to hear more about in the future. Simply contact us.